| |
| | OhioLINK ETD: TILLOTSON, JOHN |
 | | Extended-release tablets of bumetanide were developed and evaluated for the impact on bumetanide release by: extended-release polymer concentration, filler excipient type and concentration, pH of dissolution media, ICH accelerated storage conditions, formula reproduction, and media pH and solubility modifiers. |
 | | Bumetanide release was slowed as the fraction of the extended-release polymer was increased from 20-60%. |
 | | Bumetanide tablets exhibited pH-dependent drug release based upon bumetanide solubility in the study media, releasing slowest in pH 1.5 HCl buffer followed by pH 4.5 phthalate buffer, USP purified water pH 5.8, and pH 6.8 phosphate buffer. |
| www.ohiolink.edu /etd/view.cgi?ucin1085067185 (355 words) |
|